Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT05211648 Completed - Hypertension Clinical Trials

COOL-BP Study: Continuous Versus Occasional Blood Pressure Study

Start date: February 10, 2022
Phase: N/A
Study type: Interventional

The COOL-BP study is part of the Remote Hypertension Program and will investigate the data provided by Aktiia Bracelet (a cuffless Blood Pressure monitor at the wrist) when integrated into the Remote Hypertension Program. The COOL BP study aims to compare weekly and monthly Blood Pressure averages measured manually by traditional Home Blood Pressure Monitoring to those measured automatically by the Aktiia bracelet.

NCT ID: NCT05208814 Completed - Clinical trials for Pulmonary Arterial Hypertension

a Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects

Start date: March 31, 2022
Phase: Phase 1
Study type: Interventional

To evaluate the effect of renal insufficiency on the pharmacokinetics of TPN171H tablets after single dose oral administration, so as to provide basis for formulating clinical medication plan for patients with renal insufficiency; To evaluate the safety of TPN171H tablets in patients with renal insufficiency and healthy subjects

NCT ID: NCT05208320 Completed - Hypertension Clinical Trials

Effectiveness of Community Health Workers in Hypertension Adherence

Start date: November 3, 2020
Phase: N/A
Study type: Interventional

A community intervention in elderly hypertension patients by Community Health Workers in order to improve patients adherence to treatment

NCT ID: NCT05202067 Completed - Type 2 Diabetes Clinical Trials

Impact of Pharmaceutical Education on Medication Adherence

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Purpose. To evaluate the impact of pharmaceutical education in patients with Type 2 Diabetes Mellitus and Systemic Arterial Hypertension on their medication adherence. Material and research methods. Randomized clinical trial with a control group with a duration of 6 months of follow-up. Patients with a diagnosis of Type 2 Diabetes Mellitus andWE Systemic Arterial Hypertension treated in the internal medicine outpatient of a school hospital will be included. Adherence to medication will be evaluated using Morisky's 8-item medication adherence scale. The investigators believe that Pharmaceutical education increases therapeutic adherence in patients with Type 2 Diabetes Mellitus and Systemic Arterial Hypertension.

NCT ID: NCT05199129 Completed - Hypertension Clinical Trials

Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients

Start date: November 17, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate of efficacy and safety of HCP1904-3 and RLD2001-1 alone in patients with essential hypertension inadequately controlled on RLD2001-1 monotherapy.

NCT ID: NCT05196854 Completed - Hypertension Clinical Trials

Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1

Start date: May 25, 2022
Phase: N/A
Study type: Interventional

This study has two primary objectives. The first is to determine if it is feasible and reliable for children and families with a diagnosis of Neurofibromatosis Type 1 (NF1) to use of blood pressure (BP) monitor at home. The second is to determine if there is a difference between a child's measured home BP using standard instructions or using a clinical hypnosis script. This will be determined by a randomised control trial design. Standard and hypnosis Home BP will be compared to the gold standard measurement of BP measured by a trained health care professional in clinic. Children who participate will complete a clinic-based BP with a health care professional, then will be randomised into either the standard home BP measurement or using a hypnosis script prior to BP measurement.

NCT ID: NCT05192356 Completed - Clinical trials for Hypertension and Dyslipidemia

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

Start date: February 23, 2022
Phase: Phase 1
Study type: Interventional

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-348(3)

NCT ID: NCT05189015 Completed - Hypertension Clinical Trials

Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension

Ang(1-7)
Start date: January 1, 2021
Phase: Phase 4
Study type: Interventional

In this study, we will assess the change of serum ACE-2, angiotensin(1-7), and vascular function after using olmesartan (an ARB), compared to conventional anti-hypertensive drug, amlodipine in hypertensive patients with T2DM.

NCT ID: NCT05187702 Completed - Clinical trials for Hypertension and Balance

The Effect of Functional Exercise Training on Patients With Hypertension

Start date: June 28, 2022
Phase: N/A
Study type: Interventional

It is the ability to keep and maintain the body training balance control center. Dynamic balance is the ability to maintain an individual's static position while the movement and posture are active while static. With aging, it is thought that the system will be applied in practice. Control of cerebral blood flow and synapse, which decreases with advanced age and hypertension, continues. In addition to slowing down in mental functions such as memory and learning, it progresses and accelerates in the sense of vibration, nerve velocity, proprioceptor feedback under skin receptor control, and can occur in static, dynamic and isokinetic muscle strength. This causes you to continue the preparations for the necessary evaluations in your postural stability and you watch. Particularly geriatrics reported that Otogo supports us to improve balance in us. The purpose of this goal is to test in otago educational work on static and dynamic movements, lower hypertensive muscle work, capacity and capacity and competence.

NCT ID: NCT05186987 Completed - Clinical trials for Pulmonary Hypertension

Visa-versa! Breaking Instead of Pushing the Pedals-A

Start date: February 15, 2022
Phase: N/A
Study type: Interventional

Eccentric muscle work is defined as lengthening of a muscle while applying force. It was shown that with eccentric work, muscles are able to perform four times as much power compared to usual concentric work, which results in huge training gain with a highly decreased oxygen demand and thus lower cardiovascular load. Pulmonary hypertension (PH) is a chronic condition associated with significant reduced exercise capacity and increased morbidity and mortality, resulting in reduced quality of life. Physical training has been shown to be beneficial in PH, even in severely limited patients. However, due to cardiopulmonary constraints in PH, training intensities may be very low, so that many patients are physically almost unable to perform exercise on a high enough level to maintain muscle mass. A low body muscle not only feeds the vicious cycle of decreasing exercise capacity, but also has many deleterious metabolic and immunological consequences which further increase disability and decrease quality of life in PH. Thus, eccentric training, which allows to gain muscle mass with a low stress to the cardiopulmonary unit may to be highly beneficial for patients with PH and allied cardiopulmonary disease, such as chronic obstructive pulmonary disease (COPD) and heart failure. Therefore, the objective of the trial is, to compare differences in oxygen uptake (peak VO2 [l/min]) and other physiological measures during similar cardiopulmonary exercise test protocols of eccentric- vs. concentric cycling in PH- patients and comparators with or without other cardiopulmonary diseases.